Hypofractionated whole breast irradiation

• 발행기관: 대한방사선종양학회
• 저자명: Kyung Su Kim Kyung Hwan Shin Noorie Choi Sea-Won Lee
• 간행물 정보: 『대한방사선종양학회지』제34권 제2호, 81~87쪽, 전체 7쪽
• 주제분류: 의약학 > 종양학
• 파일형태: PDF
• 발행일자: 2016.06.30

영문 초록

Hypofractionated whole breast irradiation (HF-WBI) has been proved effective and safe and even better for late or acute radiation toxicity for early breast cancer. Moreover, it improves patient convenience, quality of life and is expected to be advantageous in the medical care system by reducing overall cost. In this review, we examined key randomized trials of HF-WBI, focusing on adequate patient selection as suggested by the American Society of Therapeutic Radiology and Oncology (ASTRO) guideline and the radiobiologic aspects of HF-WBI in relation to its adoption into clinical settings. Further investigation to identify the current practice pattern or cost effectiveness is warranted under the national health insurance service system in Korea.

키워드

Breast neoplasms Radiotherapy Dose hypofractionation